64
Participants
Start Date
April 24, 2018
Primary Completion Date
June 9, 2018
Study Completion Date
June 9, 2018
Daprodustat 2 mg tablet
Daprodustat is available as 2 mg tablet. Subjects will receive daprodustat orally as tablet. A single dose of 2 tablets of 2 mg daprodustat will be administered in a fasted state during Part 1 of the study.
Daprodustat 4 mg tablet
Daprodustat is available as 4 mg tablet. Subjects will receive daprodustat orally as tablet. A single dose of 4 mg daprodustat will be administered in a fasted state during Part 1 and in fed and fasted state in Part 2 of the study.
GSK Investigational Site, Fukuoka
Lead Sponsor
GlaxoSmithKline
INDUSTRY